- Home
- VYGR vs SPCE Comparison
VYGR vs SPCE Comparison
Compare VYGR & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- SPCE
- Stock Information
- Founded
- VYGR 2013
- SPCE 2017
- Country
- VYGR United States
- SPCE United States
- Employees
- VYGR N/A
- SPCE N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- VYGR Health Care
- SPCE Consumer Discretionary
- Exchange
- VYGR Nasdaq
- SPCE Nasdaq
- Market Cap
- VYGR 231.9M
- SPCE 216.0M
- IPO Year
- VYGR 2015
- SPCE N/A
- Fundamental
- Price
- VYGR $4.69
- SPCE $4.00
- Analyst Decision
- VYGR Strong Buy
- SPCE Hold
- Analyst Count
- VYGR 8
- SPCE 5
- Target Price
- VYGR $16.71
- SPCE $10.45
- AVG Volume (30 Days)
- VYGR 789.3K
- SPCE 4.6M
- Earning Date
- VYGR 11-11-2025
- SPCE 11-05-2025
- Dividend Yield
- VYGR N/A
- SPCE N/A
- EPS Growth
- VYGR N/A
- SPCE N/A
- EPS
- VYGR N/A
- SPCE N/A
- Revenue
- VYGR $42,580,000.00
- SPCE $1,698,000.00
- Revenue This Year
- VYGR N/A
- SPCE N/A
- Revenue Next Year
- VYGR $107.10
- SPCE $2,908.26
- P/E Ratio
- VYGR N/A
- SPCE N/A
- Revenue Growth
- VYGR N/A
- SPCE N/A
- 52 Week Low
- VYGR $2.65
- SPCE $2.18
- 52 Week High
- VYGR $8.28
- SPCE $8.19
- Technical
- Relative Strength Index (RSI)
- VYGR 62.56
- SPCE 63.18
- Support Level
- VYGR $4.32
- SPCE $3.33
- Resistance Level
- VYGR $5.06
- SPCE $4.42
- Average True Range (ATR)
- VYGR 0.29
- SPCE 0.33
- MACD
- VYGR 0.02
- SPCE 0.07
- Stochastic Oscillator
- VYGR 64.59
- SPCE 54.62
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.